Triple-action diabetes jab shown to reduce blood sugar and body weight - The Guardian

[unable to retrieve full-text content]

1. Triple-action diabetes jab shown to reduce blood sugar and body weight  The Guardian
2. Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits  Reuters
3. Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications  investor.lilly.com
4. ADA: Lilly pulls back curtain on impressive triple-G efficacy in patients with obesity, diabetes  Fierce Biotech
5. A new wave of weight-loss therapies aims to be better than today’s GLP-1s  MarketWatch

https://news.google.com/rss/articles/CBMiqAFBVV95cUxQWjI4OFo2Z3JQUU5yeGR6Y1JyVVRKNU1uWjQ1aDdSbDBUMmJwb0FCX3JFVTNweVBjN1EteV9xTW0wbGotd0V5d0hRTHg0a0JUeHpydG9HejRnZGVpZnltc1NTb0lHckFEWkZRNFNuTmM4NnJaRV9pS3ZBV09OcnZRWGpDMGp1LTZmeEcyWkRpR0Y4VmJsWFhDQlI5cjJ2N3BoRTdOSVI2cmo?oc=5

2026-06-07 12:38:00Z
CBMiqAFBVV95cUxQWjI4OFo2Z3JQUU5yeGR6Y1JyVVRKNU1uWjQ1aDdSbDBUMmJwb0FCX3JFVTNweVBjN1EteV9xTW0wbGotd0V5d0hRTHg0a0JUeHpydG9HejRnZGVpZnltc1NTb0lHckFEWkZRNFNuTmM4NnJaRV9pS3ZBV09OcnZRWGpDMGp1LTZmeEcyWkRpR0Y4VmJsWFhDQlI5cjJ2N3BoRTdOSVI2cmo